Association of Enterotoxigenic Bacteroides fragilis with Immune Modulation in Colorectal Cancer Liver Metastasis
Cancers · 22.08.2025 · 17 (17) · 2733
DOI: 10.3390/cancers17172733 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancers, online erschienen am 22.08.2025. Verfasst von Rumiko Saito und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research (JFCR), 3-8-31 Ariake, Koto-ku, Tokyo 135-8550, Ja…. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: JSPS KAKENHI, Takeda Science Foundation, Mochida Memorial Foundation for Medical and Pharmaceutical Research.
Abstract (Originalsprache)
Background
Enterotoxigenic Bacteroides fragilis (ETBF) carries the bft toxin gene, which influences the host immune response and inflammatory pathways and promotes colorectal cancer (CRC). This study investigated the potential role of ETBF in CRC liver metastasis.
Methods
We reviewed the records of 226 consecutive patients who underwent curative-intent (R0) resection of CRC liver metastases. ETBF DNA in fresh-frozen metastasis specimens was quantified using droplet digital PCR (ddPCR). Patients were grouped into very-low (≤80%; N = 178), low (80–90%; N = 24), and high (>90%; N = 24) ETBF-DNA groups. Three tissue cores per specimen were stained for CD8, CD4, CD20, FOXP3, CD68, and CD163, and immune-cell densities were measured digitally (cells/mm2).
Results
ETBF DNA was detected in 219 of 226 lesions (96.9%). The densities of cytotoxic CD8+ T-cells, effector CD4+ T-cells, CD20+ B-cells, and CD163+ macrophages did not differ significantly by ETBF-DNA group (Ptrend all > 0.12). FOXP3+ regulatory T-cells (Tregs) decreased (Ptrend = 0.010), and CD68+ macrophages increased (Ptrend = 0.020) as ETBF-DNA levels increased. ETBF-DNA levels in CRC liver metastases were not associated with disease-free survival or overall survival or serum C-reactive protein levels.
Conclusions
ETBF was present in almost all CRC liver metastases. Higher ETBF levels were associated with a tumor-immune microenvironment enriched in CD68+ macrophages and deficient in FOXP3+ Tregs, suggesting that ETBF facilitates immune evasion without loss of effector lymphocytes. Although ETBF-DNA levels did not predict survival in this single-center cohort, the potential role of ETBF in immune remodeling and as a candidate biomarker and therapeutic target in metastatic CRC warrants further study.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research (JFCR), 3-8-31 Ariake, Koto-ku, Tokyo 135-8550, Japan.
- Department of Clinical Chemotherapy, Cancer Chemotherapy Center, Japanese Foundation for Cancer Research (JFCR), 3-8-31 Ariake, Koto-ku, Tokyo 135-8550, Japan.
- Department of Pathology, Cancer Institute Hospital, Japanese Foundation for Cancer Research (JFCR), 3-8-31 Ariake, Koto-ku, Tokyo 135-8550, Japan.
- Division of Pathology, Cancer Institute Hospital, Japanese Foundation for Cancer Research (JFCR), 3-8-31 Ariake, Koto-ku, Tokyo 135-8550, Japan.
- Division of Tumor Pathology, Jichi Medical University, 3311-1 Yakushiji, Shimotsuke 329-0431, Japan.
- Department of Pathology, Saitama Cancer Center, 780 Komuro, Ina, Kita-adachi-gun, Saitama 362-0806, Japan.
ORCID-Profile: Yasuyuki Shigematsu, Manabu Takamatsu, Yu Takahashi, Yuji Miura, Kengo Takeuchi, Kentaro Inamura
Förderung
- JSPS KAKENHI
- Takeda Science Foundation
- Mochida Memorial Foundation for Medical and Pharmaceutical Research
- Ichiro Kanehara Foundation
- Foundation for Promotion of Cancer Research in Japan
- Yakult Bio-Science Foundation
- Kobayashi Foundation for Cancer Research
Zitieren
APA
Saito, R., Shigematsu, Y., Amori, M., Amori, G., Takamatsu, M., Nishida, K., Kanda, H., Takahashi, Y., Miura, Y., Takeuchi, K., Takahashi, S., & Inamura, K. (2025). Association of Enterotoxigenic Bacteroides fragilis with Immune Modulation in Colorectal Cancer Liver Metastasis. Cancers, 17(17), 2733. https://doi.org/10.3390/cancers17172733
Vancouver
Saito R, Shigematsu Y, Amori M, Amori G, Takamatsu M, Nishida K, et al. Association of Enterotoxigenic Bacteroides fragilis with Immune Modulation in Colorectal Cancer Liver Metastasis. Cancers. 2025;17(17):2733. doi:10.3390/cancers17172733
BibTeX
@article{Saito2025,
author = {Saito, Rumiko and Shigematsu, Yasuyuki and Amori, Mahmut and Amori, Gulanbar and Takamatsu, Manabu and Nishida, Kenji and Kanda, Hiroaki and Takahashi, Yu and Miura, Yuji and Takeuchi, Kengo and Takahashi, Shunji and Inamura, Kentaro},
title = {Association of Enterotoxigenic Bacteroides fragilis with Immune Modulation in Colorectal Cancer Liver Metastasis},
journal = {Cancers},
year = {2025},
volume = {17},
number = {17},
pages = {2733},
doi = {10.3390/cancers17172733}
}
EUVIMED